In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Theravance Biopharma Inc (NASDAQ: TBPH) was $10.11 for the day, up 0.50% from the previous closing price of $10.06. In other words, the price has increased by $0.50 from its previous closing price. On the day, 0.61 million shares were traded. TBPH stock price reached its highest trading level at $10.35 during the session, while it also had its lowest trading level at $9.9.
Ratios:
Our analysis of TBPH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.74 and its Current Ratio is at 5.74. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 12, 2024, initiated with a Buy rating and assigned the stock a target price of $21.
On May 23, 2022, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $12.SVB Leerink initiated its Outperform rating on May 23, 2022, with a $12 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 10 ’24 when Farnum Rhonda sold 4,000 shares for $9.00 per share. The transaction valued at 36,000 led to the insider holds 335,965 shares of the business.
Samaha Eli bought 1,499,124 shares of TBPH for $13,117,335 on May 01 ’24. The 10% Owner now owns 8,511,350 shares after completing the transaction at $8.75 per share. On Feb 22 ’24, another insider, Farnum Rhonda, who serves as the SVP, COMM & MEDICAL AFFAIRS of the company, sold 1,254 shares for $8.71 each. As a result, the insider received 10,922 and left with 311,733 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TBPH now has a Market Capitalization of 494125216 and an Enterprise Value of 437178240. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.99 while its Price-to-Book (P/B) ratio in mrq is 2.40. Its current Enterprise Value per Revenue stands at 7.107 whereas that against EBITDA is -10.474.
Stock Price History:
Over the past 52 weeks, TBPH has reached a high of $11.71, while it has fallen to a 52-week low of $8.13. The 50-Day Moving Average of the stock is 12.27%, while the 200-Day Moving Average is calculated to be 6.69%.
Shares Statistics:
TBPH traded an average of 375.56K shares per day over the past three months and 297620 shares per day over the past ten days. A total of 48.09M shares are outstanding, with a floating share count of 44.70M. Insiders hold about 8.10% of the company’s shares, while institutions hold 101.73% stake in the company. Shares short for TBPH as of 1721001600 were 5642020 with a Short Ratio of 15.02, compared to 1718323200 on 6291069. Therefore, it implies a Short% of Shares Outstanding of 5642020 and a Short% of Float of 22.770001.
